Corporate Banner
Satellite Banner
Stem Cells, Cellular Therapy & Biobanking
>
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Titian Software Exhibits at ESBB Conference 2011

Published: Thursday, November 03, 2011
Last Updated: Thursday, November 03, 2011
Bookmark and Share
Engaging with leaders in the field of biobanking.

Titian Software has announced its attendance at the 2011 ESBB Biobanking Conference, 16th - 19th November 2011, Marseille, France.

Edmund Wilson (CEO) and David Booth (Regional Sales Manager) will be on Booth 42 to demonstrate Mosaic, Titian’s renowned modular sample management software, and explore with delegates any specific biobank sample management requirements.

The ESBB Conference is being held back-to-back with the BioSHaRE Annual Meeting 2011. Registration to attend the ESBB conference is now open.

Mosaic sample management software allows compounds and biological samples to be efficiently tracked and monitored within any sample storage and handling system.

Chosen by 13 out of the top 20 bio-pharma companies, Mosaic has been proven to streamline sample management processes in large and small-scale operations, including centralized sample banks or smaller sample stores within a laboratory.

Mosaic minimizes human error in sample preparation and simplifies operations within the lab, whilst improving sample preservation.

The software tracks cryovials, tissue cartridges, slide arrays, microtubes and plates, and implements a chain of custody for the handling of the sample according to the requested order type.

Many sample types are managed simultaneously, with configurable details such as freeze-thaw cycles being recorded against containers, and sample consent parameters being recorded against individual samples.

Order status is closely monitored to track the success or failure of each step in the ordering process, creating a full audit trail of actions for reference.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More than 5,000+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Nanosensors Could Determine Tumours’ Ability to Remodel Tissue
Researchers design nanosensors that can profile tumours, focusing on protease levels.
1960s Antibiotics Show Promise for TB Therapy
Research suggests antibiotics introduced in 1963 to treat bacterial infections show promise for tuberculosis therapy.
Insight into Eye Diseases
Scientists recreate zebrafish cell regeneration from retinal stem cells in mice.
Analysing 10,000 Cells Simultaneously
New techniquethat traps 10,000 cells on a single chip has potential for cancer screening for individuals.
Studies Explore the Science of Cardiovascular Diseases
Two studies highlight how basic science research insights are key to future treatment breakthroughs.
Stem Cell ‘Heart Patch’ Almost Perfected
Scientists aiming to perfect and test 3D "heart patches" in animal model, last hurdle before human patients.
Using Stem Cells to Grow a 3D Lung-in-a-Dish
Researchers have created 3D lung-like tissue from lung-derived stem cells. The tissue can be used to study lung diseases.
MRI Guidance Aids Stem Cell Delivery
Scientists have delivered stem cells to the brain with unprecedented precision, infusing the cells under real-time MRI guidance.
Mechanisms of Parkinson’s Pathology
Defects that lead to cells’ failure to decommission faulty mitochondria cause nerve cells to die, triggering the symptoms of Parkinson’s disease.
Advanced Lymphoma in Remission After T-Cell Therapy
63% of trial participants who recieved two-drug combination chemo plus intermediate dose of engineered T cells went into complete remission.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!